Showing results (111-120 of 307) with videos related to
Sort By:
Pageof 31
Joint Bone Spine|April 10, 2013
New bone formation in axial spondyloarthritisDaniel Wendling, Pascal ClaudepierreJoint Bone Spine|July 7, 2014
Current treatment of psoriatic arthritis: update based on a systematic literature review to establish French Society for Rheumatology (SFR) recommendations for managing spondyloarthritisJulien Paccou, Daniel WendlingCurrent Opinion in Rheumatology|June 7, 2007
Antiinflammatory treatment with bisphosphonates in ankylosing spondylitisEric Toussirot, Daniel WendlingExpert Opinion on Pharmacotherapy|February 16, 2005
Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathiesEric Toussirot, Daniel WendlingDrugs & Aging|June 25, 2005
Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment optionsEric Toussirot, Daniel WendlingThe Journal of Rheumatology|August 17, 2012
Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of RheumatologyDaniel Wendling, Maxime Dougados, Francis Berenbaum, et al.Arthritis Research & Therapy|June 6, 2023
Increased gut permeability and intestinal inflammation precede arthritis onset in the adjuvant-induced model of arthritisSophie Hecquet, Perle Totoson, Hélène Martin, et al.Joint Bone Spine|January 25, 2019
Translocation of dead or alive bacteria from mucosa to joints and epiphyseal bone-marrow: facts and hypothesesJean-Marie Berthelot, Daniel WendlingJoint Bone Spine|December 12, 2003
Hemarthrosis in acquired hemophilia. Two case-reportsDaniel Wendling, Marie-Anne BertrandRecent Patents on Inflammation & Allergy Drug Discovery|December 17, 2008
Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a reviewEric Toussirot, Gérald Streit, Daniel WendlingPageof 31